| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.77B | 24.44B | 20.78B | 19.49B | 18.51B | 17.76B |
| Gross Profit | 9.71B | 11.16B | 9.09B | 7.85B | 6.99B | 5.88B |
| EBITDA | 6.29B | 7.34B | 5.51B | 4.58B | 3.95B | 3.14B |
| Net Income | 3.90B | 4.89B | 3.33B | 2.63B | 2.33B | 1.64B |
Balance Sheet | ||||||
| Total Assets | 19.38B | 21.53B | 18.48B | 15.72B | 13.41B | 11.50B |
| Cash, Cash Equivalents and Short-Term Investments | 9.93B | 12.14B | 9.35B | 8.38B | 6.97B | 4.95B |
| Total Debt | 0.00 | 100.00M | 100.00M | 100.00M | 100.00M | 100.00M |
| Total Liabilities | 5.51B | 5.45B | 5.10B | 4.77B | 4.13B | 4.02B |
| Stockholders Equity | 13.87B | 16.07B | 13.38B | 10.95B | 9.29B | 7.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.88B | 3.42B | 2.57B | 2.57B | 1.56B |
| Operating Cash Flow | 0.00 | 5.91B | 3.52B | 3.55B | 3.28B | 2.29B |
| Investing Cash Flow | 0.00 | -1.12B | -1.48B | -1.13B | -696.63M | -713.17M |
| Financing Cash Flow | 0.00 | -2.00B | -1.07B | -1.00B | -549.06M | -701.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥97.33B | 15.64 | ― | 1.19% | 16.77% | 13.72% | |
82 Outperform | ¥109.74B | 10.90 | ― | 1.02% | 23.44% | 74.38% | |
77 Outperform | ¥68.98B | 14.80 | 31.71% | 1.68% | 17.64% | 47.00% | |
74 Outperform | ¥87.04B | 11.45 | ― | 2.59% | 7.79% | 9.07% | |
70 Outperform | ¥23.25B | 7.22 | ― | 4.58% | 6.58% | 35.23% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥130.20B | 1,327.31 | ― | ― | 30.48% | ― |